Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
This consultation siought views on how current guidance can be expanded to provide additional support for community pharmacists following forthcoming legislative changes to the Medicines For Human Use (Prescribing By EEA Practitioners) Regulations 2008 (2008 Regulations).
It also sought views on a proposals to allow the emergency sale of phenobarbitone or phenobarbitone sodium for the treatment of epilepsy under the 2008 regulations.
More details on the consultation are available in the letter below and the outcome of this consultation is available below as a download document.
Download documents:
-
Outcome of MLX 370: MLX 370: intention to further amend the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 SI 2008/1692) (16Kb)
-
Public consultation (MLX 370): Intention to further amend the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 (SI 2008/1692) (125Kb)
